These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15857115)

  • 1. Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor.
    Hedfors A; Appelqvist T; Carlsson B; Bladh LG; Litten C; Agback P; Grynfarb M; Koehler KF; Malm J
    J Med Chem; 2005 May; 48(9):3114-7. PubMed ID: 15857115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity.
    Malm J; Gordon S; Brandt P; Carlsson B; Agback P; Bäckbro Saeidi A; Sandberg J
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2018-21. PubMed ID: 17254783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
    Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
    J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid receptor ligands. 6. A high affinity "direct antagonist" selective for the thyroid hormone receptor.
    Koehler K; Gordon S; Brandt P; Carlsson B; Bäcksbro-Saeidi A; Apelqvist T; Agback P; Grover GJ; Nelson W; Grynfarb M; Färnegårdh M; Rehnmark S; Malm J
    J Med Chem; 2006 Nov; 49(23):6635-7. PubMed ID: 17154490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor beta (TR-beta) selective ligands.
    Raval S; Raval P; Bandyopadhyay D; Soni K; Yevale D; Jogiya D; Modi H; Joharapurkar A; Gandhi N; Jain MR; Patel PR
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3919-24. PubMed ID: 18585912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.
    Nascimento AS; Dias SM; Nunes FM; Aparício R; Ambrosio AL; Bleicher L; Figueira AC; Santos MA; de Oliveira Neto M; Fischer H; Togashi M; Craievich AF; Garratt RC; Baxter JD; Webb P; Polikarpov I
    J Mol Biol; 2006 Jul; 360(3):586-98. PubMed ID: 16781732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid receptor ligands. Part 4: 4'-amido bioisosteric ligands selective for the thyroid hormone receptor beta.
    Li YL; Litten C; Koehler KF; Mellström K; Garg N; Garcia Collazo AM; Färnegård M; Grynfarb M; Husman B; Sandberg J; Malm J
    Bioorg Med Chem Lett; 2006 Feb; 16(4):884-6. PubMed ID: 16303304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-alpha-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141.
    Garg N; Li YL; Garcia Collazo AM; Litten C; Ryono DE; Zhang M; Caringal Y; Brigance RP; Meng W; Washburn WN; Agback P; Mellström K; Rehnmark S; Rahimi-Ghadim M; Norin T; Grynfarb M; Sandberg J; Grover G; Malm J
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4131-4. PubMed ID: 17543524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Only subtle protein conformational adaptations are required for ligand binding to thyroid hormone receptors: simulations using a novel multipoint steered molecular dynamics approach.
    Martínez L; Polikarpov I; Skaf MS
    J Phys Chem B; 2008 Aug; 112(34):10741-51. PubMed ID: 18681473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulating alpha/beta selectivity at the human thyroid hormone receptor: consensus scoring using multidimensional QSAR.
    Vedani A; Zumstein M; Lill MA; Ernst B
    ChemMedChem; 2007 Jan; 2(1):78-87. PubMed ID: 17096449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of yeast reporter assay systems to detect ligands of thyroid hormone receptors alpha and beta.
    Shiizaki K; Asai S; Ebata S; Kawanishi M; Yagi T
    Toxicol In Vitro; 2010 Mar; 24(2):638-44. PubMed ID: 19853653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a thyroid hormone receptor targeting conjugate.
    Zheng J; Hashimoto A; Putnam M; Miller K; Koh JT
    Bioconjug Chem; 2008 Jun; 19(6):1227-34. PubMed ID: 18507428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the denaturation mechanisms of the ligand binding domain of thyroid hormone receptors.
    Martínez L; Souza PC; Garcia W; Batista FA; Portugal RV; Nascimento AS; Nakahira M; Lima LM; Polikarpov I; Skaf MS
    J Phys Chem B; 2010 Jan; 114(3):1529-40. PubMed ID: 20043653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants of selective thyromimetics.
    Yoshihara HA; Apriletti JW; Baxter JD; Scanlan TS
    J Med Chem; 2003 Jul; 46(14):3152-61. PubMed ID: 12825953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.
    Łazewska D; Kuder K; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2008 Sep; 16(18):8729-36. PubMed ID: 18774720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel thyroid hormone receptor antagonists with an N-alkylated diphenylamine skeleton.
    Komatsu T; Hirano T; Songkram C; Kawachi E; Kagechika H
    Bioorg Med Chem; 2007 May; 15(9):3115-26. PubMed ID: 17363258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid receptor ligands. Part 5: novel bicyclic agonist ligands selective for the thyroid hormone receptor beta.
    Garcia Collazo AM; Koehler KF; Garg N; Färnegårdh M; Husman B; Ye L; Ljunggren J; Mellström K; Sandberg J; Grynfarb M; Ahola H; Malm J
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1240-4. PubMed ID: 16338239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta.
    Hangeland JJ; Doweyko AM; Dejneka T; Friends TJ; Devasthale P; Mellström K; Sandberg J; Grynfarb M; Sack JS; Einspahr H; Färnegårdh M; Husman B; Ljunggren J; Koehler K; Sheppard C; Malm J; Ryono DE
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3549-53. PubMed ID: 15177471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1.
    Takeuchi K; Holloway WG; McKinzie JH; Suter TM; Statnick MA; Surface PL; Emmerson PJ; Thomas EM; Siegel MG; Matt JE; Wolfe CN; Mitch CH
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5349-52. PubMed ID: 17720493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.